scholarly journals Effect of Vitamin B12 and Folic Acid Supplementation on Bone Mineral Density and Quantitative Ultrasound Parameters in Older People with an Elevated Plasma Homocysteine Level: B-PROOF, a Randomized Controlled Trial

2015 ◽  
Vol 96 (5) ◽  
pp. 401-409 ◽  
Author(s):  
Anke W. Enneman ◽  
Karin M. A. Swart ◽  
Janneke P. van Wijngaarden ◽  
Suzanne C. van Dijk ◽  
Annelies C. Ham ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Homocysteine Level ◽  
Controlled Trial ◽  
Folic Acid Supplementation ◽  
Plasma Homocysteine ◽  
Elevated Plasma ◽  
Mineral Density ◽  
Plasma Homocysteine Level ◽  
Randomized Controlled ◽  
Ultrasound Parameters

scholarly journals Calcium supplementation and bone mineral density in females from childhood to young adulthood: a randomized controlled trial

2005 ◽  
Vol 81 (1) ◽  
pp. 175-188 ◽  
Author(s):  
Velimir Matkovic ◽  
Prem K Goel ◽  
Nancy E Badenhop-Stevens ◽  
John D Landoll ◽  
Bin Li ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Randomized Controlled Trial ◽  
Young Adulthood ◽  
Bone Mineral ◽  
Calcium Supplementation ◽  
Controlled Trial ◽  
Mineral Density ◽  
Randomized Controlled

Effect of a low-impact exercise program on bone mineral density in Crohn's disease: A randomized controlled trial

1998 ◽  
Vol 115 (1) ◽  
pp. 36-41 ◽  
Author(s):  
Richard J. Robinson ◽  
Tara Krzywicki ◽  
Len Almond ◽  
Farook Al–Azzawi ◽  
Keith Abrams ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Randomized Controlled Trial ◽  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Bone Mineral ◽  
Controlled Trial ◽  
Exercise Program ◽  
Mineral Density ◽  
Randomized Controlled ◽  
Impact Exercise

scholarly journals Influence of Hydroxyapatite Coating for the Prevention of Bone Mineral Density Loss and Bone Metabolism after Total Hip Arthroplasty: Assessment Using 18F-Fluoride Positron Emission Tomography and Dual-Energy X-Ray Absorptiometry by Randomized Controlled Trial

2020 ◽  
Vol 2020 ◽  
pp. 1-9
Author(s):  
Taro Tezuka ◽  
Naomi Kobayashi ◽  
Choe Hyonmin ◽  
Masatoshi Oba ◽  
Yushi Miyamae ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Positron Emission Tomography ◽  
Controlled Trial ◽  
Dual Energy ◽  
Emission Tomography ◽  
Mineral Density ◽  
X Ray ◽  
Randomized Controlled ◽  
Ha Coating ◽  
Positron Emission

Background. Hydroxyapatite- (HA-) coated implants tend to achieve good osteoinductivity and stable clinical results; however, the influence of the coating on the prevention of bone mineral density (BMD) loss around the implant is unclear. The purpose of this randomized controlled trial was to evaluate the effectiveness of HA-coated implants for preventing BMD loss and to determine the status of bone remodeling after total hip arthroplasty (THA), making comparisons with non-HA-coated implants. Methods. A total of 52 patients who underwent primary THA were randomly allocated to HA and non-HA groups. BMD was measured by dual-energy X-ray absorptiometry (DEXA) at 1 week postoperation to form a baseline measurement, and then 24 weeks and 48 weeks after surgery. The relative change in BMD was evaluated for regions of interest (ROIs) based on the Gruen zone classifications. 18F-fluoride positron emission tomography (PET) was performed at 24 weeks postsurgery, and the maximum standardized uptake values (SUVmax) were evaluated in the proximal (HA-coated) and distal (non-HA-coated) areas in both groups. Results. There were significant differences in BMD loss in ROIs 3 and 6 (p=0.03), while no significant difference was observed in ROI 7 at either 24 or 48 weeks postsurgery. There was no significant correlation between PET uptake and BMD (24 or 48 weeks) in either group. Conclusion. The influence of a HA coating in terms of BMD preservation is limited. No significant correlation was found between BMD and SUVmax measured by PET, either with or without the use of a HA coating.

Sign in / Sign up

Export Citation Format

Share Document